Chronic Kidney Disease and Cardiovascular Disease Clinical Trials

You might qualify for the Chronic Kidney Disease Research Study!

Kidneys play a crucial role in filtering toxins from the body, but kidney issues frequently lead to cardiovascular problems by disrupting fluid and electrolyte balance. This imbalance increases the risk of developing Atherosclerotic Cardiovascular Disease, Heart Failure, and other conditions. Despite advancements in medicine and treatments, there remains an unmet need for effective interventions to prevent and manage cardiovascular complications associated with chronic kidney disease.

At Revival Research Institute, we are conducting Chronic Kidney Disease and Cardiovascular Disease Clinical Trials evaluating the safety and effectiveness of an investigational drug in people with cardiovascular diseases and chronic kidney disease.

You may be eligible for the Cardiovascular and Chronic Kidney Disease Clinical Trials if you:

• 45 years of age, or older
• Have a BMI >27.0 kg/m2
• Have established Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease diagnosis

*Additional criteria may apply

This Cardiovascular Disease and Chronic Kidney Disease Clinical Trial will observe whether the investigational medication helps manage the symptoms of chronic kidney disease that contribute to heart diseases.

*Participation in the clinical trial is completely free of cost and voluntary.
**To participate, fill out the form and someone from our research staff will call you to see if you are eligible for the clinical research study.

Once you agree to take part in the Chronic Kidney Disease and Cardiovascular Disease Clinical Trials, you will be asked to sign an Informed Consent Form that has all the details of the study. The study team will also be there to guide you about the process and your role in the study trial. We highly encourage all our participants to ask as many questions as they’d like, before participation. In the end, the decision is all yours whether to take part or walk out of the trial.

Once the consent form is signed and all your questions are answered, you will be assigned to a group by random selection. The two groups in the Cardiovascular Disease and Chronic Kidney Disease Research Study are:

• Control group
• Experimental group

The control group is given a placebo medication that does not have an active ingredient of the medicine, whereas the experimental group is the one that is being treated with an actual study drug that has active ingredients. The study team is also unaware of the allocation as it is a double-blind research study, meaning neither the researcher nor the participant knows which treatment or intervention is being given to them.

In case of an emergency, the information about your study treatment at the Chronic Kidney Disease and Cardiovascular Disease Clinical Trials will be revealed to your study doctor.